Peer-reviewedCC BYHeartRhythm case reports
How to individualize device therapy in transthyretin cardiac amyloidosis: A dyssynchrony-based case report.
- 1Department of Cardiology, Necmettin Erbakan University, School of Medicine, Konya, Türkiye.
Related
- One-minute heart rate recovery and clinical outcomes in transthyretin cardiac amyloidosis: incremental model fit beyond conventional CPET indices
- Closing the diagnostic gap in transthyretin cardiac amyloidosis: red flags, modern imaging, and emerging therapies
- Delayed Diagnosis of Hereditary Transthyretin Cardiac Amyloidosis Presenting with Autonomic Neuropathy: A Case Report
- Demographic Representation in Clinical Trials for Transthyretin-Associated Cardiac Amyloidosis: A Systematic Review
- Survival Outcomes in Transthyretin Cardiac Amyloidosis in the Tafamidis Era: Real-World Evidence from Greece
BibTeX
@article{sahin2026individualize,
title = {{How to individualize device therapy in transthyretin cardiac amyloidosis: A dyssynchrony-based case report.}},
author = {Ahmet Taha Sahin and Ahmet Lutfu Sertdemir and Yakup Alsancak and Mustafa Celik and Enes Elvin Gul},
journal = {HeartRhythm case reports},
year = {2026},
month = jul,
doi = {10.1016/j.hrcr.2026.07.015},
url = {https://europepmc.org/article/MED/42923210},
note = {CC BY},
}
RIS
TY - JOUR
TI - How to individualize device therapy in transthyretin cardiac amyloidosis: A dyssynchrony-based case report.
AU - Ahmet Taha Sahin
AU - Ahmet Lutfu Sertdemir
AU - Yakup Alsancak
AU - Mustafa Celik
AU - Enes Elvin Gul
PY - 2026
DA - 2026/07/29
JO - HeartRhythm case reports
DO - 10.1016/j.hrcr.2026.07.015
UR - https://europepmc.org/article/MED/42923210
SN - 2214-0271
ER -